Hypotrichosis Clinical Trial
This one-year study evaluates the long-term safety and effectiveness of bimatoprost solution application to the eyelid margin (where the eyelashes meet the skin) to treat hypotrichosis of the eyelashes (inadequate or not enough eyelashes). There will be two different types of subjects participating in the study 1)those with inadequate eyelashes due to natural causes or 2) those with inadequate eyelashes following a complete course of chemotherapy treatment. There will be two treatment periods of six months each. Subjects will receive either the study medication or vehicle in either of the two treatment periods.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01448525 -
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
|
Phase 4 | |
| Completed |
NCT00958035 -
Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis
|
Phase 4 | |
| Completed |
NCT01891487 -
Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows
|
Phase 4 | |
| Completed |
NCT01387906 -
Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
|
Phase 4 | |
| Recruiting |
NCT05790941 -
Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation
|
Early Phase 1 | |
| Recruiting |
NCT05723198 -
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
|
Phase 3 | |
| Completed |
NCT01200251 -
Study of Bimatoprost Gel on Eyelash Growth
|
Phase 3 |